D,L-α-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, induces differentiation in MEL cells

Cell Biology International

Volumn 23, Issue 7, 1999, Pages 489-495

  Choudhary, Shailesh Kumar ^a   Sharma, Dipali ^a   Dixit, Aparna ^a  

^a JAWAHARLAL NEHRU UNIVERSITY   (India)

Author keywords

D,L difluoromethylornithine; Differentiation; Murine erythroleukemia cells

Indexed keywords

BROXURIDINE; DEXAMETHASONE; EFLORNITHINE; HEMOGLOBIN;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; ERYTHROLEUKEMIA CELL; MOUSE; NONHUMAN;

ANIMALIA; MURINAE;

EID: 0033492924     PISSN: 10656995     EISSN: None     Source Type: Journal    
DOI: 10.1006/cbir.1999.0398     Document Type: Article

References (48)

1. Adesnik M, Snitkin H. Induction of erythroid differentiation in Friend leukemia cells by bromodeoxyuridine. J Cell Physiol. 95:1978;307-318.
2. Arndt-Jovin DJ, Ostertag W, Eisen H, Klimek F, Jovin TM. Studies of cellular differentiation by automated cell separation. Two model systems: Friend virus-transformed cells andHydra attenuata. Cell. 24:1976;332-347.
3. Ask A, Heby O. Increased survival of L1210 leukemic mice by prevention of the utilization of extracellular polyamines. Studies using a polyamine uptake mutant, antibiotics, and a polyamine-deficient diet. Cancer Lett. 66:1992;29-34.
4. Ask A, Persson L, Seiler N, Heby O. Antileukemic effects of non-metabolizable derivatives of spermidine and spermine. Cancer Lett. 69:1993;33-38.
5. Aziz SM, Gillespie MN, Crooks PA, Tofiq S-F, Tsuboi C-P, Olson J-W, Gosland M-P. The potential of a novel polyamine transport inhibitor in cancer chemotherapy. J Pharmacol Exp Therapeutics. 278:1996;185-192.
6. Basu HS, Pellarin M, Feuerstein BG, Shirahata A, Samejima K, Deen DF, Marton LJ. Interaction of a polyamine analogue 1,19-bis-(ethylamino)-5,10,15-triazanonadecane(BE4-4-4-4), with DNA and effect on growth, survival, and polyamine levels in seven human brain tumor cell lines. Cancer Res. 53:1993;3948-3955.
7. Boyle JO, Meyskens FL Jr, Carewal HS, Gerner EW. Polyamine contents in rectal and buccal mucosae in humans treated with oral difluoromethyl ornithine. Cancer Epidemiol Biomarkers Prev. 1:1992;131-135.
8. Canellakis ZE, Marsh LL, Bondy PK. Polyamines and their derivatives as modulators in growth and differentiation. The Yale J. Biol. Med. 62:1989;481-491.
9. Chen KY, Presepe V, Parken N, Liu AVC. Changes of ornithine decarboxylase activity and polyamine content upon differentiation of mouse NB-15 neuroblastoma cells. J Cell Physiol. 110:1982;285-290.
10. Chen Z, Banks J, Rifkind RA, Marks PA. Inducer-mediated commitment of murine erythroleukemia cells to differentiation: a multi-step process. Proc Natl Acad Sci U S A. 79:1982;471-475.
11. Cohen R, Pacific M, Rubinstein N, Biehl J, Woldzer H. Effect of a tumor promoter on Myogenesis. Nature. 266:1977;538-540.
12. Dube, SK, Gaedicke, G, Kluge, N, Weimann, B, Melderis, H, Steinheider, G, Crozier, T, Beckmann, H, Ostertag, W, 1974, Haemoglobin-synthesizing mouse and human erythroleukemic cell lines as model systems for the study of differentiation and control of gene expression, Nakahara, E, Differentiation and control of malignancy of tumor cells, Tokyo, University of Tokyo Press, 99, 132.
13. Ebert P-S, Ikawa Y. Induction of S-aminoleulinic acid synthetase during erythroid differentiation of cultured leukemia cells. Proc Soc Exp Biol Med. 146:1974;601-604.
14. Friend C, Scher W, Holland JG, Sato T. Haemoglobin synthesis in murine virus-induced leukemic cells in vitro: stimulation of erythroid differentiation by dimethyl sulfoxide. Proc Natl Acad Sci U S A. 68:1971;378-382.
15. Garg L-C, Brown J-C. Friend erythroleukemia cell differentiation: induction by retinoids. Differentiation. 25:1983;79-83.
16. He Y, Shimogori T, Kashiwagi D, Shirahata A, Igarashi K. Inhibition of cell growth by combination of α-difluoromethylornithine and an inhibitor of spermine synthase. J Biochem. 117:1995;824-829.
17. Heby O, Luk GD, Schindler J. Polyamine synthesis inhibitors act as both inducers and suppressors of cell differentiation. McCann PP, Pegg AE, Sjoerdsma A. Inhibition of polyamine metabolism. Biological significance and basis for new therapies. 1987;165-186 Academic Press, Orlando.
18. Holtta E, Auvine M, Andersson L-C. Polyamines are essential for cell transformation by pp60v0src: Delineation of molecular events for the transformed phenotype. J Cell Biol. 122:1993;903-909.
19. Kadmon D. Chemoprevention in prostate cancer: the role of difluoromethyl ornithine (DFMO). J Cell Biochem Suppl. 16:1992;122-127.
20. Koch G, Weber C, Bilelleo JA. Alterations in translational control mechanisms in Friend erythroleukemic cells during dimethylsulfoxide induced differentiation. Hematol Bluttransfus. 23:1979;295-301.
21. Levenson R, Housman D. Memory of MEL cells to a previous exposure to inducer. Cell. 17:1979;485-490.
22. Loprinzi CL, Messing FM. A prospective clinical trial of difluoromethyl ornithine (DFMO) in patients with resected superficial bladder cancer. J Cell Biochem Suppl. 161:1992;153-155.
23. Lotem J, Sachs J. Regulation of normal differentiation in mouse and human myeloid leukemia cells by phorbol esters and the mechanism of tumor promotion. Proc Natl Acad Sci U S A. 76:1979;5158-5162.
24. Mager D, Bernstein A. Early transport changes during erythroid differentiation of Friend leukemic cells. J Cell Physiol. 94:1978;275-286.
25. Marks PA, Rifkind RA. Erythroleukemia differentiation. Annu Rev Biochem. 47:1978;419-448.
26. Meyskens FL Jr, Gerner EW. Development of difluoromethyl ornithine as a chemoprevention agent for the management of colon cancer. J Cell Biochem Suppl. 22:1995;126-131.
27. Miyaura C, Abe E, Kuribayashi T, Tanaka H, Konno K, Nishii Y, Suda T. 1α, 25-dihydroxy vitamin D3 induces differentiation of human myeloid leukemia cells. Biochem Biophys Res Commun. 102:1981;937-943.
28. Ohmori T, Okada K, Tabei R, Shibata T. Effects on tumor induction, growth, metastasis and histology of concurrent administration of putrescine and its metabolizing inhibitor α-difluoromethylornithine in nickel tumorigenesis in soft tissue. Carcinogenesis. 15:1994;647-652.
29. Orkin SH, Harosi FI, Leder P. Differentiation in erythroleukemic cells and their somatic hybrids. Proc Natl Acad Sci U S A. 72:1975;98-102.
30. Pegg AE. Polyamine metabolism and its importance in neoplastic growth and as a target for chemotherapy. Cancer Res. 48:1988;744-759.
31. Pegg AE, Shantz LM, Coleman CS. Ornithine decarboxylase as a target for chemoprevention. J Cell Biochem Suppl. 22:1995;132-138.
32. Pegg AE, Shantz LM, Coleman CS. Ornithine decarboxylase as a target for chemoprevention. J Cell Biochem Suppl. 22:1995;132-138.
33. Pomidor MM, Ruhl KK, Zheng P, Song Y, Joanne OA, Tuan RS, Hickok NJ. Relationship between ornithine decarboxylase cytoskeletal organization in cultured human keratinocytes: cellular responses to phorbol esters, cytochalasins and alph difluoromethylornithine. Exp Cell Res. 221:1995;426-437.
34. 12-bis(ethyl)spermine in L1210 leukaemia cells. Biochem J. 312:1995;749-756.
35. Radhika S, Choudhary SK, Garg LC, Dixit A. Induction of differentiation in murine erythroleukemia cells by 1α, 25-dihydroxy vitamin D3. Cancer Lett. 90:1995;225-230.
36. Rath NC, Reddi AH. Changes in ornithine decarboxylase activity during matrix-induced cartilage, bone and bone marrow differentiation. Biochem Biophys Res Commun. 81:1978;106-113.
37. Ross J, Ikawa Y, Leder P. Globin messenger RNA induction during erythroid differentiation of cultured leukemia cells. Proc Natl Acad Sci U S A. 79:1972;3620-3623.
38. Rovera G, O'Brien T, Diamond L. Tumour promoters inhibit spontaneous differentiation of Friend erythroleukemia cells in culture. Proc Natl Acad Sci U S A. 74:1977;2894-2896.
39. Sachs L. Control of normal cell differentiation and the phenotypic reversion of malignancy in meyloid leukemia. Nature. 284:1978;535-539.
40. Sarhan S, Bolkenius FN, Rennert OM. Polyamine deprivation, malnutrition and tumor growth. Anticancer Res. 12:1992;457-466.
41. Sassa S. Sequential induction of enzymes of the heme biosynthetic pathway in Friend erythroleukemia cells in culture. J Exp Med. 143:1976;305-315.
42. Schindler J, Kelly M, McCann PP. Inhibition of ornithine decarboxylase induces embryonal carcinoma cell differentiation. Biochem Biophys Res Commun. 114:1983;410-417.
43. Seiler N, Dezeure F. Polyamine transport in mammalian cells. Int J Biochem. 22:1990;211-218.
44. Sugiura M, Shafman T, Kafe D. Effects of polyamine depletion on proliferation and differentiation of murine erythroleukemia cells. Cancer Res. 44:1984;1440-1444.
45. Takigawa M, Takano T, Suzuki F. Effects of parathyroid hormones and cyclic AMP analogues on the activity of ornithine decarboxylase and expression of the differentiated phenotype of chondrocytes in culture. J Cell Physiol. 106:1981;259-268.
46. Toursarkissian B, Endean ED, Aziz SM. Characterization of polyamine transport in rat aortic smooth muscle cells. J Surg Res. 57:1994;401-407.
47. Watanabe T, Sherman M, Shafman T, Iwata T, Kufe D. Effects of ornithine decarboxylase inhibition on c-myc expression during murine erythroleukemia cell proliferation and differentiation. J Cell Physiol. 127:1986;480-484.
48. Yamaguchi Y, Kluuge N, Ostertag W, Furusawa M. Erythroid differentiation and commitment in rat erythroleukemia cells with hypertonic culture conditions. Proc Natl Acad Sci U S A. 78:1981;2325-2329.